Back

Pacemaker implantation due to cardiac conduction disease in patients with subsequent cardiac sarcoidosis may be a marker of early disease and is associated with adverse 5-year clinical outcome

29 August 2022 (17:15 - 18:00)
Organised by:
Congress Presentation Part of: Evaluation and treatment of conduction disease in 2022 Atrioventricular (AV) Block ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Anna Slattman

Skane University Hospital, Lund (Sweden)

7 More presentations in this session

Presentation thumbnail
Results of permanent lead implantation at the His bundle without the use of an electrophysiological unit
Associate Professor C. Israel (Bielefeld, DE)
Abstract Slides
Presentation thumbnail
Patient reported symptoms in emergency health care service in patients with complete atrioventricular block
Doctor C. Bang (Soeborg, DK)
Abstract Slides
Presentation thumbnail
Etiologies and predictors for cardiac implantable electronic device implantation in young patients hospitalized for complete atrioventricular block
Doctor G. Margolis (Hadera, IL)
Abstract Slides
Presentation thumbnail
Type 2 diabetes is associated with higher risk of 3rd degree atrioventricular block: a Danish nationwide registry study
Doctor S. Haxha (Lund, SE)
Abstract Slides
Presentation thumbnail
A novel scoring system to predict cardiac device implantation in patients presenting with syncope
Doctor A. Khan (Birmingham, GB)
Abstract Slides

Access the full session

Session thumbnail
Evaluation and treatment of conduction disease in 2022

The Event

Event poster

ESC Congress 2022

29 August 2022 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Sinus node dysfunction and atrioventricular conduction disorder following acute myocardial infarction
thumbnail
Congress Presentation
Sinus bradycardia and atrioventricular block in the sportsman: emerging evidence of an intrinsic cause
thumbnail
Congress Presentation
All types of atrioventricular block due to hypervagotonia in a 16-year-old female

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources